Financial reports
10-K
2023 FY
Annual report
19 Mar 24
10-Q
2023 Q3
Quarterly report
7 Nov 23
10-Q
2023 Q2
Quarterly report
10 Aug 23
10-Q
2023 Q1
Quarterly report
4 May 23
ARS
2022 FY
Annual report to shareholders
17 Apr 23
10-K
2022 FY
Annual report
22 Mar 23
10-Q
2022 Q3
Quarterly report
3 Nov 22
10-Q
2022 Q2
Quarterly report
4 Aug 22
10-Q
2022 Q1
Quarterly report
5 May 22
10-K
2021 FY
Annual report
3 Mar 22
Current reports
8-K
Tyra Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights
19 Mar 24
8-K
Tyra Biosciences, Inc. Announces $200 Million Private Placement Financing
5 Feb 24
8-K
Other Events
1 Feb 24
8-K
Other Events
22 Dec 23
8-K
Tyra Biosciences Reports Third Quarter 2023 Financial Results and Highlights
7 Nov 23
8-K
Amendments to Articles of Incorporation or Bylaws
26 Oct 23
8-K
Tyra Biosciences Reports Second Quarter 2023 Financial Results and Highlights
10 Aug 23
8-K
Submission of Matters to a Vote of Security Holders
2 Jun 23
8-K
Tyra Biosciences Reports First Quarter 2023 Financial Results and Highlights
4 May 23
8-K
Tyra Biosciences Reports Fourth Quarter and Full Year 2022 Financial Results and Highlights
22 Mar 23
Registration and prospectus
S-8
Registration of securities for employees
19 Mar 24
S-3
Shelf registration
19 Mar 24
D
Exempt offering of security
13 Feb 24
S-3
Shelf registration
3 Oct 22
S-8
Registration of securities for employees
15 Sep 21
424B4
Prospectus supplement with pricing info
15 Sep 21
S-1MEF
Registration of additional securities for an S-1
14 Sep 21
S-1/A
IPO registration (amended)
14 Sep 21
8-A12B
Registration of securities on exchange
10 Sep 21
S-1/A
IPO registration (amended)
9 Sep 21
Other
EFFECT
Notice of effectiveness
14 Oct 22
CORRESP
Correspondence with SEC
11 Oct 22
UPLOAD
Letter from SEC
11 Oct 22
EFFECT
Notice of effectiveness
15 Sep 21
CERT
Certification of approval for exchange listing
13 Sep 21
CORRESP
Correspondence with SEC
10 Sep 21
CORRESP
Correspondence with SEC
10 Sep 21
CORRESP
Correspondence with SEC
20 Aug 21
CORRESP
Correspondence with SEC
20 Aug 21
UPLOAD
Letter from SEC
13 Jul 21